Authors
Latest:
Drug Utilization Patterns in Patients With Alzheimer's DiseaseThe proportion of Americans diagnosed with Alzheimer's disease (AD) is projected to increase almost 2-fold over the next couple of decades due to size of the Baby Boom generation compared with the total US population.
Latest:
Handling Professional Ghosting in PharmacyIf you are either seeking employment or want to move forward with your career, understanding the consequences of professional ghosting is a must in 2020.
Latest:
Specialty Pharmacy Data Standards in a Rapidly Evolving Value-Based WorldSpecialty medications also are the fastest growing cost component of total health care costs.
Latest:
Fosfomycin UseFosfomycin (Monurol) is an antibiotic that uses a unique mechanism of action to establish its bactericidal activity.
Latest:
340B Oversight: Interdisciplinary Approach Ensures Continuous ComplianceThe 340B drug pricing program was enacted in 1992.
Latest:
Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-ReleaseTherapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.
Latest:
Specialty Pharmacy and Health Care ReformHealth care reform and the increasing pipeline of specialty have created a "perfect storm" of significant business and financial impacts to patients, insurers, health care providers, manufacturers, and pharmacies.
Latest:
Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan ReexaminationMedicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.
Latest:
An Externship in Public HealthIn recent years, career options for pharmacists have grown beyond the traditional settings of retail drugstores and hospitals.
Latest:
Evaluation of Dual Versus Triple Therapy for Hepatitis CIn this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.
Latest:
Findings Related to Assessing Value for Private US Health PlansA qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.
Latest:
Predictors of Healthcare Costs After Initiating Dabigatran Versus WarfarinThe study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.
Latest:
Medication Therapy Management and Health Care ReformThe changes that the Affordable Care Act has brought to the practice of pharmacy may not be well known.
Latest:
Tips for Managing Adverse Drug ReactionsFear of adverse drug events often influences adherence decisions.
Latest:
High Expectations Accompany Specialty Drug TherapiesClinical outcomes have different meanings among specialty pharmacy stakeholders.
Latest:
The Importance of Provider Status for PharmacistsThroughout the pandemic, pharmacists have played a critical role in the COVID-19 response in several ways
Latest:
Treating COVID-19 or Rheumatoid Arthritis? Exploring Proposed Drug Therapy, Safety ConcernsWhat characteristics of RA treatments possibly connect to COVID-19 treatment?
Latest:
Real-World Evidence Enters the Discussion for Biosimilar SwitchingDedicated clinical trials in IBD cohorts that scrutinized biosimilar use in real-world clinical practice have direct implications on decision making.
Latest:
Are You a Pharmacist and a Mom?Currently, more women practice in pharmacy than men, and it is expected that the number of women practicing will continue to rise.
Latest:
Lessons Learned: How Health-System Pharmacy Technicians Are Tackling COVID-19The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.
Latest:
Schizophrenia Costs for Newly Diagnosed Versus Previously Diagnosed PatientsPreviously diagnosed schizophrenia patients have lower inpatient and higher drug costs compared with newly diagnosed patients, possibly indicating better control of their disease.
Latest:
Quantitative Analysis of 2 Treatment Options for Osteoarthritis in Adults: Intra-Articular Hyaluronan Products and DiacereinEmpirical findings suggest that hyaluronan injections and diacerein are similarly effective. Yet the authors found that monetary savings could be realized when conservative treatment with diacerein is chosen.
Latest:
Benralizumab for Severe Eosinophilic AsthmaBenralizumab (Fasenra) is indicated as an add-on therapy for patients with severe eosinophilic asthma.
Latest:
Vaccine Vial Disposal GuidelinesThe Immunization and Infectious Disease initiative for Healthy People 2020 goal is to “increase immunization rates and reduce preventable infectious diseases.”
Latest:
Five Technology Trends: Changing Pharmacy Practice Today and TomorrowHIT creates value for pharmacies and opportunities for pharmacists to use their professional skills in innovative ways in today's evolving value-based care systems.
Latest:
Strategies to Overcome the Readmission Crisis in Health SystemsHealth care is in the midst of a transformation in which health care providers are increasingly being paid for value provided rather than per service.
Latest:
Smartphones and Social Media: Transforming Health CareLeverage mobile technology to make the delivery of health care easy, low in cost, and comfortable for the patient.
Latest:
Thiamine and Magnesium in Obesity: A Possible Factor in Disease Prevention and Co-TreatmentA recent systematic review has shed light on increased glucose intake in the modern diet and the effects on mechanisms in the body.
